Dr Anthony L Morton, MD | |
10810 Connecticut Avenue, Kensington, MD 20895-2138 | |
(301) 929-7100 | |
(301) 929-7114 |
Full Name | Dr Anthony L Morton |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 44 Years |
Location | 10810 Connecticut Avenue, Kensington, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457427643 | NPI | - | NPPES |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kaiser Foundation Health Plan Of The Mid-atlantic States,inc | 3779495858 | 1673 |
News Archive
Scientists have used mass spectrometry for decades to determine the chemical composition of samples but rarely has it been used to identify viruses, and never in complex environmental samples.
Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that new data from its landmark pivotal onychomycosis trial first published in the peer-reviewed Journal of the American Podiatric Medical Association (JAPMA) has once again been published in this prestigious journal. The new paper, which reports on a 270 day onychomycosis clinical trial, offers further scientific support for using the Noveon lasers as an effective therapeutic treatment.
Tom Daschle, the former Senate Majority Leader and a senior, informal, advisor to President Obama during the health debate has been writing and talking about how the law got passed.
Close on the heels of a large-scale clinical trial just underway to confirm that the female hormone estriol combats the effects of multiple sclerosis (MS) in women, a just completed pilot study at UCLA now shows promise for the use of testosterone to combat its effects in men.
The Actionable Bladder Symptom Screening Tool is a reliable, valid and sensitive instrument in women with incontinence due to non-neurogenic overactive bladder, researchers report.
› Verified 2 days ago
Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
Scientists have used mass spectrometry for decades to determine the chemical composition of samples but rarely has it been used to identify viruses, and never in complex environmental samples.
Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that new data from its landmark pivotal onychomycosis trial first published in the peer-reviewed Journal of the American Podiatric Medical Association (JAPMA) has once again been published in this prestigious journal. The new paper, which reports on a 270 day onychomycosis clinical trial, offers further scientific support for using the Noveon lasers as an effective therapeutic treatment.
Tom Daschle, the former Senate Majority Leader and a senior, informal, advisor to President Obama during the health debate has been writing and talking about how the law got passed.
Close on the heels of a large-scale clinical trial just underway to confirm that the female hormone estriol combats the effects of multiple sclerosis (MS) in women, a just completed pilot study at UCLA now shows promise for the use of testosterone to combat its effects in men.
The Actionable Bladder Symptom Screening Tool is a reliable, valid and sensitive instrument in women with incontinence due to non-neurogenic overactive bladder, researchers report.
› Verified 2 days ago
Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1366781700 PECOS PAC ID: 3779495858 Enrollment ID: O20130507000207 |
News Archive
Scientists have used mass spectrometry for decades to determine the chemical composition of samples but rarely has it been used to identify viruses, and never in complex environmental samples.
Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that new data from its landmark pivotal onychomycosis trial first published in the peer-reviewed Journal of the American Podiatric Medical Association (JAPMA) has once again been published in this prestigious journal. The new paper, which reports on a 270 day onychomycosis clinical trial, offers further scientific support for using the Noveon lasers as an effective therapeutic treatment.
Tom Daschle, the former Senate Majority Leader and a senior, informal, advisor to President Obama during the health debate has been writing and talking about how the law got passed.
Close on the heels of a large-scale clinical trial just underway to confirm that the female hormone estriol combats the effects of multiple sclerosis (MS) in women, a just completed pilot study at UCLA now shows promise for the use of testosterone to combat its effects in men.
The Actionable Bladder Symptom Screening Tool is a reliable, valid and sensitive instrument in women with incontinence due to non-neurogenic overactive bladder, researchers report.
› Verified 2 days ago
Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
---|---|
Entity Type | Part B Supplier - Ambulatory Surgical Center |
Entity Identifiers | NPI Number: 1497023188 PECOS PAC ID: 3779495858 Enrollment ID: O20131029000108 |
News Archive
Scientists have used mass spectrometry for decades to determine the chemical composition of samples but rarely has it been used to identify viruses, and never in complex environmental samples.
Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that new data from its landmark pivotal onychomycosis trial first published in the peer-reviewed Journal of the American Podiatric Medical Association (JAPMA) has once again been published in this prestigious journal. The new paper, which reports on a 270 day onychomycosis clinical trial, offers further scientific support for using the Noveon lasers as an effective therapeutic treatment.
Tom Daschle, the former Senate Majority Leader and a senior, informal, advisor to President Obama during the health debate has been writing and talking about how the law got passed.
Close on the heels of a large-scale clinical trial just underway to confirm that the female hormone estriol combats the effects of multiple sclerosis (MS) in women, a just completed pilot study at UCLA now shows promise for the use of testosterone to combat its effects in men.
The Actionable Bladder Symptom Screening Tool is a reliable, valid and sensitive instrument in women with incontinence due to non-neurogenic overactive bladder, researchers report.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Anthony L Morton, MD 2101 E Jefferson St, Kaiser Permanente Medicare Enrollment, Rockville, MD 20852-4908 Ph: (301) 816-2424 | Dr Anthony L Morton, MD 10810 Connecticut Avenue, Kensington, MD 20895-2138 Ph: (301) 929-7100 |
News Archive
Scientists have used mass spectrometry for decades to determine the chemical composition of samples but rarely has it been used to identify viruses, and never in complex environmental samples.
Nomir Medical Technologies, Inc., a leader in novel photobiology and laser therapies, announced today that new data from its landmark pivotal onychomycosis trial first published in the peer-reviewed Journal of the American Podiatric Medical Association (JAPMA) has once again been published in this prestigious journal. The new paper, which reports on a 270 day onychomycosis clinical trial, offers further scientific support for using the Noveon lasers as an effective therapeutic treatment.
Tom Daschle, the former Senate Majority Leader and a senior, informal, advisor to President Obama during the health debate has been writing and talking about how the law got passed.
Close on the heels of a large-scale clinical trial just underway to confirm that the female hormone estriol combats the effects of multiple sclerosis (MS) in women, a just completed pilot study at UCLA now shows promise for the use of testosterone to combat its effects in men.
The Actionable Bladder Symptom Screening Tool is a reliable, valid and sensitive instrument in women with incontinence due to non-neurogenic overactive bladder, researchers report.
› Verified 2 days ago
Dr. Shannon Penick Pryor, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 10810 Connecticut Avenue, Kensington, MD 20895 Phone: 301-929-7100 Fax: 301-929-7114 | |
Dr. Gregory R Sater, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 10810 Connecticut Ave, Kaiser Permanente Kensington Medical Center, Kensington, MD 20895 Phone: 301-929-7100 | |
Dr. Eric Charles Sklarew, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 10810 Connecticut Ave, Kaiser Permanente Keensington Medical Center, Kensington, MD 20895 Phone: 301-929-7159 Fax: 301-929-7438 | |
Dr. Deborah Dee Yee Cheung, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 10810 Connecticut Ave, Kensington, MD 20895 Phone: 301-929-7086 Fax: 301-929-7438 |